Transfusion efficacy of novel anticoagulant‐preservative solution in a rat model of decompensated hemorrhagic shock
Transfusion · 2026
DOI: 10.1111/trf.70117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2026. Verfasst von Kristin M Reddoch-Cardenas und 9 weiteren Autor:innen. Beteiligte Einrichtung: U.S. Army Institute of Surgical Research, JBSA-FT, Sam Houston, Texas, USA. Hauptthemen laut MEDLINE: Shock, Hemorrhagic, Anticoagulants, Blood Preservation, Blood Transfusion. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Combat Casualty Care Research Program.
Abstract (Originalsprache)
Background
Hemorrhagic shock remains a leading cause of preventable death. Whole blood (WB) transfusion provides comprehensive resuscitation but is limited by storage‐related degradation under standard refrigerated citrate‐phosphate‐dextrose‐adenine (CPDA‐1) conditions. A novel additive solution (APEX) was designed to mitigate storage lesions and extend WB functionality. This study evaluated the hemostatic preservation and resuscitative efficacy of APEX‐stored WB in a rat model of decompensated hemorrhagic shock. Study Design and Methods WB was collected from anesthetized donor rats into CPDA‐1 or CPDA‐1 + APEX (7:5 ratio) and stored refrigerated (1–6°C) for 14 days. Recipient rats underwent a fixed‐volume (65% estimated blood volume) hemorrhage followed by resuscitation with stored WB. Physiologic recovery, hemostatic function (rotational thromboelastometry [ROTEM]), and metabolic parameters were assessed over 120 min post‐hemorrhage.
Results
APEX‐stored WB maintained comparable platelet and leukocyte counts and hemostatic indices to CPDA‐1 WB after 14 days. Rats resuscitated with APEX WB showed improved metabolic recovery over CPDA‐1, exhibiting significantly lower lactate ( p = .022) and higher glucose ( p = .021) levels at 120 min post‐hemorrhage. Coagulation parameters (obtained by ROTEM) remained near baseline in APEX‐treated animals, whereas CPDA‐1 WB induced a hypercoagulable, fibrinolytic profile. A modest increase in lung wet/dry ratio was observed in the APEX group, with no intestinal edema.
Discussion
In this preclinical model, we observed that APEX additive solution preserved rat WB quality and supported superior physiological recovery compared with standard CPDA‐1 storage. These pilot findings support further investigation of APEX as an alternative WB storage technology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- U.S. Army Institute of Surgical Research, JBSA-FT, Sam Houston, Texas, USA.
- Hemerus Medical LLC, St. Paul, Minnesota, USA.
ORCID-Profile: Kristin M Reddoch-Cardenas, Xiaowu Wu
Förderung
- Combat Casualty Care Research Program
Zitieren
APA
Reddoch-Cardenas, K. M., Wu, X., Keesee, J. D., Liu, B., Lopez, M. M., Kelly, S., McIntosh, C., Meledeo, M. A., Jensen, L., & Zia, M. (2026). Transfusion efficacy of novel anticoagulant‐preservative solution in a rat model of decompensated hemorrhagic shock. Transfusion. https://doi.org/10.1111/trf.70117
Vancouver
Reddoch-Cardenas KM, Wu X, Keesee JD, Liu B, Lopez MM, Kelly S, et al. Transfusion efficacy of novel anticoagulant‐preservative solution in a rat model of decompensated hemorrhagic shock. Transfusion. 2026. doi:10.1111/trf.70117
BibTeX
@article{ReddochCardenas2026,
author = {Reddoch-Cardenas, Kristin M and Wu, Xiaowu and Keesee, Jeffery D and Liu, Bin and Lopez, Monica M and Kelly, Scott and McIntosh, Colby and Meledeo, Michael A and Jensen, Lynn and Zia, Majid},
title = {Transfusion efficacy of novel anticoagulant‐preservative solution in a rat model of decompensated hemorrhagic shock},
journal = {Transfusion},
year = {2026},
doi = {10.1111/trf.70117}
}
EUVIMED